GAMMA Investing LLC Has $82,000 Holdings in Maximus, Inc. $MMS

GAMMA Investing LLC lifted its stake in Maximus, Inc. (NYSE:MMS) by 60.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,174 shares of the health services provider’s stock after buying an additional 442 shares during the period. GAMMA Investing LLC’s holdings in Maximus were worth $82,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd raised its stake in Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock worth $36,000 after acquiring an additional 526 shares in the last quarter. UMB Bank n.a. increased its position in shares of Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock worth $41,000 after purchasing an additional 250 shares in the last quarter. NBC Securities Inc. increased its holdings in shares of Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider’s stock worth $78,000 after buying an additional 1,149 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock worth $84,000 after buying an additional 303 shares in the last quarter. Finally, LRI Investments LLC increased its holdings in shares of Maximus by 11.9% during the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider’s stock worth $125,000 after buying an additional 195 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat, Maximus currently has an average rating of “Strong Buy” and an average price target of $90.00.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the completion of the sale, the insider directly owned 13,508 shares of the company’s stock, valued at $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by company insiders.

Maximus Stock Up 0.5%

NYSE MMS opened at $91.29 on Friday. The stock has a fifty day moving average of $84.70 and a 200-day moving average of $75.18. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The stock has a market capitalization of $5.14 billion, a P/E ratio of 16.81 and a beta of 0.57. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.73.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the previous year, the company earned $1.74 EPS. Maximus’s revenue was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, August 15th. Maximus’s payout ratio is currently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.